Oral Contraceptive Pills: Benefits Beyond Contraception
Abstract
No abstract
References
1. NHFS 4 (National Family Health Survey) 2015-16, Ministry of Health and Family Welfare, Government of India.
2. Reference Manual for Oral Contraceptive Pills. March 2016. Family Planning Division Ministry of Health and Family Welfare, Government of India.
3. ACOG Practice Bulletin No. 110: Non-contraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206.
4. Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynecology Canada, July 2017, Volume 39, Issue 7, Pages 585–595
5. Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology 2016; 34(24):2888-2898
6. Michels KA, Pfeiffer RM, Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncology 2018.
7. Fernandez E, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001; 84:722–7.
8. Burkman RT. Review Oral contraceptives: current status. Clin Obstet Gynecol. 2001 Mar; 44(1):62-72
9. Royal College of Obstetricians and Gynaecologists. GTG 33: Long Term Consequences of Polycystic Ovary Syndrome. Greentop Guideline No. 33. London: RCOG; 2007
10. Drossaers-Bakker KW, Zwinderman AH, et al. Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis. 2002 May; 61(5):405-8.
2. Reference Manual for Oral Contraceptive Pills. March 2016. Family Planning Division Ministry of Health and Family Welfare, Government of India.
3. ACOG Practice Bulletin No. 110: Non-contraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206.
4. Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynecology Canada, July 2017, Volume 39, Issue 7, Pages 585–595
5. Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology 2016; 34(24):2888-2898
6. Michels KA, Pfeiffer RM, Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncology 2018.
7. Fernandez E, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001; 84:722–7.
8. Burkman RT. Review Oral contraceptives: current status. Clin Obstet Gynecol. 2001 Mar; 44(1):62-72
9. Royal College of Obstetricians and Gynaecologists. GTG 33: Long Term Consequences of Polycystic Ovary Syndrome. Greentop Guideline No. 33. London: RCOG; 2007
10. Drossaers-Bakker KW, Zwinderman AH, et al. Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis. 2002 May; 61(5):405-8.
Published
2020-02-24
How to Cite
Dr Reena Wani, Dr. Rashmi Jalvee. (2020). Oral Contraceptive Pills: Benefits Beyond Contraception. The Indian Practitioner, 73(2), 9-11. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/924
Section
Editorial
